This compound is a pharmaceutical intermediate featuring a homocysteine dimer structure with trifluoroacetyl protecting groups. It is primarily used in the custom synthesis of peptide-based active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 255387-50-9
Ethyl 6-bromohexanoate
pharmaceutical intermediate
2-Methyl-3-phenyloxirane-2-carboxylic acid
pharmaceutical intermediate
N-(2-nitrophenyl)pyridin-4-amine
pharmaceutical intermediate
N-methyl-N'-nitromethoxymethanimidamide
pharmaceutical intermediate
(2S)-4-[[(3S)-3-carboxy-3-[(2,2,2-trifluoroacetyl)amino]propyl]disulfanyl]-2-[(2,2,2-trifluoroacetyl)amino]butanoic acid
YAJJPBDKGWHGFJ-WDSKDSINSA-N
C(CSSCC[C@@H](C(=O)O)NC(=O)C(F)(F)F)[C@@H](C(=O)O)NC(=O)C(F)(F)F
—